Researchers at UC Davis Health have identified a striking chemical pattern in the brains of people with anxiety disorders: consistently lower levels of choline, an essential nutrient that supports memory, mood, and nerve signaling. In a meta-analysis published in Molecular Psychiatry, a Nature journal, scientists reviewed data from 25 previous studies encompassing 370 people with anxiety disorders and 342 without, uncovering what may be the first measurable neurochemical signature shared across multiple anxiety diagnoses.
The finding is both specific and surprising. People with anxiety disorders had approximately 8% lower brain choline levels than those in control groups—a difference that, while modest in appearance, carries significant weight in brain chemistry. The pattern emerged most clearly in the prefrontal cortex, the region responsible for regulating thought, emotion, decision-making, and behavior. "An 8% lower amount doesn't sound like that much, but in the brain it's significant," said Richard Maddock, senior author and a psychiatrist and research professor at UC Davis's Department of Psychiatry and Behavioral Sciences.
Anxiety disorders remain the most common mental illness in the United States, affecting roughly 30% of adults, yet many people do not receive adequate treatment. The conditions—including generalized anxiety disorder, panic disorder, social anxiety disorders, and phobias—are rooted in how the brain responds to stress and threat. Typically, two brain regions work together: the amygdala, which signals danger or safety, and the prefrontal cortex, which manages planning and emotional control. When anxiety disorders develop, this balance shifts. Everyday concerns feel overwhelming, and the body's stress response becomes difficult to regulate.
The UC Davis researchers suggest a novel mechanism: chronic activation of the body's fight-or-flight response, driven by elevated levels of norepinephrine, may increase the brain's demand for choline beyond what the body can supply. Choline is essential for forming cell membranes and supporting crucial brain functions, but the body produces only small amounts—most must come from diet. When the brain's demand outpaces supply, choline levels drop.
Maddock and his colleague Jason Smucny, an assistant professor in the Department of Psychiatry and Behavioral Sciences, used a noninvasive imaging technique called proton magnetic resonance spectroscopy, or 1H-MRS, to measure choline levels without surgery. The method uses magnetic fields and radio waves within an MRI machine to detect chemical concentrations in brain tissue. Maddock had previously observed low choline in studies of people with panic disorder, work that prompted the larger meta-analysis. The consistency of the 8% reduction across different anxiety disorders—rather than finding it in only one condition—stood out as remarkable.
The implications are cautious but intriguing. Smucny noted that the findings "suggest nutritional approaches—like appropriate choline supplementation—may help restore brain chemistry and improve outcomes for patients." Yet the researchers stopped short of claiming supplements are proven treatments; the discovery opens a door rather than providing a map. What's clear is that for the first time, researchers have identified a shared chemical pattern in anxiety disorders, one grounded in decades of brain imaging research and the analysis of hundreds of individuals. That specificity offers hope to the millions struggling with anxiety—not just a label for their experience, but a measurable, potentially modifiable target in the brain itself.